MENU menu

Ellen Agler

CEO, The END Fund


Ellen serves as the Chief Executive Officer of the END Fund, working to see an end of the suffering caused by the most prevalent neglected tropical diseases (NTDs) – including river blindness, lymphatic filariais, intestinal worms, schistosomiasis and blinding trachoma – affecting over 1.5 billion people. The END Fund is a collaborative platform for global philanthropic, corporate and individual donors to actively invest in a portfolio of NTD control and elimination programs through targeted investments in international and local NGOs, governments, health agencies, technical assistance, and research partners. The END Fund currently supports programs in almost 30 countries in Africa, the Middle East, and Asia. Previously, Ellen served as Operation Smile’s Senior Vice President for International Programs, managing programs to provide comprehensive care to children with cleft lips and cleft palates in over 60 countries in Latin America, the Middle East, Africa and Asia. She also led Operation Smile’s global public policy, collaboration and advocacy efforts to promote essential surgery as an integral component of global health policy and programming. Ellen holds graduate degrees in International Health from the Harvard School of Public Health, with a focus on humanitarian affairs, and in Development Studies from the London School of Economics, with a focus on non-profit management and child rights. She has also done postgraduate studies in Conflict Resolution at Universidad de Javeriana in Bogota, Colombia. She has a forthcoming book (summer 2018), Treatment Under the Big Tree: Stories from the Modern Fight to End Neglected Tropical Diseases (Johns Hopkins Press).